What is the Angiotensin Receptor Blocker (ARB) with the longest half-life?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The longest half-life ARB is telmisartan, with a half-life of approximately 24 hours. This is based on the study by 1, which states that telmisartan has the longest plasma half-life among all ARBs.

Key Points

  • Telmisartan's long half-life allows for sustained 24-hour blood pressure control, making it a highly effective antihypertensive agent 1.
  • The medication works by blocking the binding of angiotensin II to its receptors, preventing vasoconstriction and aldosterone release, thereby reducing blood pressure 2.
  • Telmisartan is generally well-tolerated, but patients should be monitored for hypotension, hyperkalemia, and renal function changes, especially when starting therapy 3.
  • ARBs, including telmisartan, are contraindicated during pregnancy and should not be combined with ACE inhibitors or aliskiren in patients with diabetes 4.

Benefits of Telmisartan

  • Sustained 24-hour blood pressure control with once-daily dosing, improving medication adherence 5.
  • Effective in reducing blood pressure in patients with mild to moderate hypertension, with a good safety profile 5.
  • May have a greater beneficial effect on long-term cardiovascular risk due to its ability to control the early morning blood pressure surge 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.